Nathalie Y. Rosin

Statistics

Publications

Citations

908

H-Index

Active since

2010

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Technische Universität Braunschweig

Nathalie Y. Rosin is an author at The University of Texas MD Anderson Cancer Center specializing in life sciences, microbiology, and antimicrobial resistance in urinary tract infections.

Publications per year

2010–2015

Publications

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study

Jan A. Burger, Michael J. Keating, William G. Wierda et al. · The Lancet Oncology · 2014 · 332 citations

Pharmacy, Immunology, Pharmacology +14

The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization

Julia Hoellenriegel, Dirk Zboralski, Christian Maasch et al. · Blood · 2013 · 236 citations · Full text

Medicine, Cell Biology, Oncology +8

The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL

Kumudha Balakrishnan, Marisa Peluso, Min Fu et al. · Leukemia · 2015 · 167 citations · Full text

Life Sciences, Cell Biology, Pharmacology +16

Genotypic and phenotypic characterization of Pseudomonas aeruginosa isolates from urinary tract infections

Petra Tielen, Maike Narten, Nathalie Y. Rosin et al. · International Journal of Medical Microbiology · 2010 · 64 citations

Life Sciences, Infectious Diseases, Microbiology +14

Susceptibility of Pseudomonas aeruginosa Urinary Tract Isolates and Influence of Urinary Tract Conditions on Antibiotic Tolerance

Maike Narten, Nathalie Y. Rosin, Max Schobert et al. · Current Microbiology · 2011 · 51 citations

Life Sciences, Infectious Diseases, Microbiology +16

1–5 of 7